Company
Blueprint Medicines Corp (0001597264)
Standardized SEC financial data for Blueprint Medicines Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001597264 · Pharmaceutical Preparations.
Gross margin
96.0%
Net margin
-13.2%
Revenue growth (YoY)
104.0%
Return on equity
-22.5%
Free cash flow
-$197.2M
Debt / equity
0.01×
Current ratio
2.85×
EPS (diluted)
$-1.07
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $66.5M | $793.7M | $180.1M | $204.0M | $249.4M | $508.8M |
| Cost of revenue |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $548.0M | $1.55B | $215.1M | $124.9M | $81.5M | $113.6M |
| Inventory |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$278.0M | $387.0M | -$298.7M | -$502.3M | -$436.8M | -$192.6M |
| Capital expenditures |
Get 0001597264 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001597264/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001597264/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"